Harms of TRIPS Waiver Expansion

Harms of TRIPS Waiver Expansion

Waiving commitments to protect intellectual property (IP) rights on COVID-19 technologies is unnecessary and harmful, with medicine supply far exceeding global demand. Any expansion of the TRIPS waiver would outsource America’s manufacturing jobs, weaken our biopharmaceutical leadership and undercut medical innovation. Learn more in the full report.

Harms of TRIPS Waiver Expansion